(Total Views: 312)
Posted On: 02/22/2018 11:03:48 PM
Post# of 72446
Well then I think you'll agree that we'll pretty easily hit that target and can see why I believe 2018 will be the year of IPIX.
$15M upfront + phase 3 trial costs in addition to milestones and royalties is probably quite realistic for a B indication. Others on iHub such as BioHedge have posited similar numbers.
I'll be more than happy to dine on pie in the sky when we get there. For now let's work on clawing our way back above a $100M market cap.
Go IPIX!
$15M upfront + phase 3 trial costs in addition to milestones and royalties is probably quite realistic for a B indication. Others on iHub such as BioHedge have posited similar numbers.
I'll be more than happy to dine on pie in the sky when we get there. For now let's work on clawing our way back above a $100M market cap.
Go IPIX!
(1)
(1)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
